Literature DB >> 15671076

Renal cells express a functional interleukin-15 receptor.

Noa Tejman-Yarden1, Moshe Zlotnik, Eli Lewis, Ohad Etzion, Cidio Chaimovitz, Amos Douvdevani.   

Abstract

BACKGROUND: Interleukin (IL)-15 is a pleiotropic cytokine known to be involved in graft rejection and to serve as a survival factor for leukocytes and epithelial cells, including renal cells. It utilizes a heterotrimeric receptor complex that consists of the IL-2 receptor betagammac subunits (IL-2/15Rbetagammac) and a unique high-affinity alpha-chain responsible for IL-15 specificity.
METHODS: The cDNA of IL-15Ralpha main mRNA product was isolated from primary human tubular epithelial cells (TEC) and sequenced. IL-15R expression in TEC and in murine renal tissue was demonstrated using western blotting, ligand binding and flow cytometry. TEC were activated with combinations of IL-15, IL-2 and interferon-gamma (IFN-gamma), and mRNA and protein levels of IL-15R were determined. Jak-STAT tyrosine phosphorylation was assayed following IL-15 exposure.
RESULTS: The full-length alpha-chain mRNA bearing exons 1-7 is expressed in TEC. IL-15Ralpha protein was detected on intact cells by flow cytometry and in extracts of human and mice renal cells using a specific anti-IL-15Ralpha antibody and by ligand-binding assay. The three subunits of the IL-15R were similarly expressed in cortex and medulla of mice kidney. Stimulation of TEC with IFN-gamma upregulated the alpha-chain while IL-2 and IL-15 had no effect on its expression. A short IL-15 stimulation of TEC induced tyrosine phosphorylation of the main IL-15 signalling molecules (Jak-1, Jak-3, STAT-3 and STAT-5).
CONCLUSIONS: Our data demonstrate the presence of a functional IL-15 receptor in the kidney. Since renal cells produce IL-15, this cytokine may have an autocrine/paracrine regulatory role in the kidney.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15671076     DOI: 10.1093/ndt/gfh616

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.

Authors:  Christian M Capitini; Terry J Fry; Crystal L Mackall
Journal:  Am J Immunol       Date:  2009-01-01

2.  Smooth muscle homeostasis in human atherosclerotic plaques through interleukin 15 signalling.

Authors:  Jelger J van der Meer; Onno J de Boer; Peter Teeling; Chris M van der Loos; Mark C Dessing; Allard C van der Wal
Journal:  Int J Clin Exp Pathol       Date:  2011-03-22

3.  Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.

Authors:  D Bernardo; J A Garrote; Y Allegretti; A León; E Gómez; J F Bermejo-Martin; C Calvo; S Riestra; L Fernández-Salazar; A Blanco-Quirós; F Chirdo; E Arranz
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

4.  Interleukin-15 plays a central role in human kidney physiology and cancer through the γc signaling pathway.

Authors:  Julien Giron-Michel; Sandy Azzi; Krystel Khawam; Erwan Mortier; Anne Caignard; Aurore Devocelle; Silvano Ferrini; Michela Croce; Hélène François; Lola Lecru; Bernard Charpentier; Salem Chouaib; Bruno Azzarone; Pierre Eid
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

5.  Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions.

Authors:  Sandy Azzi; Cindy Gallerne; Cristina Romei; Vincent Le Coz; Rosaria Gangemi; Krystel Khawam; Aurore Devocelle; Yanhong Gu; Stefania Bruno; Silvano Ferrini; Salem Chouaib; Pierre Eid; Bruno Azzarone; Julien Giron-Michel
Journal:  Neoplasia       Date:  2015-06       Impact factor: 5.715

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.